spacer
home > ebr > Spring 2016
PUBLICATIONS

European Biopharmaceutical Review

ebr
Spring 2016

   
Text
PDF
Editor’s Letter

EBR’s Editor Deborah O’Neil ponders the impact of the digital age on pharma and the improved data handling this facilitates, along with other focus features in this edition.
 
view
download pdf
Science and Innovation
Wearable Technology

Technically Speaking


Despite the growing popularity of health technologies, much uncertainty still surrounds digital healthcare and the exact definition of this ever-expanding field, say CMS Life Sciences Group’s Sarah Hanson and Laura Lucy.
 
view
download pdf
Smart Healthcare

Intelligent Design


The Internet of Things is the latest wave of technology sweeping the healthcare landscape, observes Jonathan Wilkins at European Automation – who assesses some of the radical and potentially life-saving technologies it could bring.
 
view
download pdf
Automation Advances

Rise of the Machines


Recent advances in cognitive computing could drastically shake up the industry, states IBM's Institute for Business Value’s Heather Fraser, enabling fast and more accurate decisionmaking by healthcare professionals to enhance patient care.
 
view
download pdf
bullet
Discovery Technology
Biologics Characterisation

Compare the Market


The characterisation of biological products has become ever-more reliant on advanced technology, states Fredrik Sundberg at GE Healthcare. He explains why surface plasmon resonance and sensorgram comparison offer vast benefits.
 
view
download pdf
Molecular Analysis

Measuring Up Nicely


A “fast, absolute and inherently simple method”, the emerging Taylor dispersion analysis system offers unique benefits compared to other long-established techniques, say Dr Steve Carrington and Dr Lisa Newey-Keane at Malvern Instruments.
 
view
download pdf
Microscopy Advances

Culture Shift


The modern cell culture microscope is continuing to assist researchers improve workflow efficiency and make new discoveries. Olympus Europa’s Joachim Kirschner highlights where he believes light microscopy can take science in the near future.
 
view
download pdf
bullet
Biodevelopment and Manufacturing
Supply Chain Agility

Quick on the Draw


Agility – within all stages of pharma manufacturing – is key to achieving success in company goals, believes Mark Evenepoel at AMPLEXOR Life Sciences.
 
view
download pdf
Sample Preservation

From Collection to Destruction


All biological samples, whether successful or not, could prove valuable in future biomarker studies – which is why extreme care must be taken when handling and transporting these highly delicate products, explains Eric Hayashi at LabConnect.
 
view
download pdf
bullet
CANCER FOCUS
Q&A: Rare Cancer Treatments

Making Waves


As recent reports reveal that acute myeloid leukaemia – a rare cancer form – is expected to rise with an ageing population, Actinium Pharmaceuticals Dragan Cicic describes how a promising new radio-immunotherapy treatment could boost patient survival rates.
 
view
download pdf
Immunotherapy Advances

Armed Against Cancer


CAR-T cell therapy – which involves engineering patients’ own immune cells to detect and attack tumours – is giving rise to a new generation of groundbreaking cancer treatments, including NKG2D, which could wipe out up to 80% of cancers, reports Christian Homsy at Celyad.
 
view
download pdf
Oncology Research

Modify This


Alfred Hansel and Martina Schmitz at oncgnostics GmbH explain the growing popularity of epigenetic modifications in cancer treatment.
 
view
download pdf
bullet
BUSINESS STRATEGY
Medical Affairs

Surveying Change


Dr Fabio Gambini, Paolo Morelli and Mary Wieder at PM Clinical talks about the relatively new Medical Sciences Liaison role, and how plans to outsource this vital function could impact on the industry.
 
view
download pdf
In Brief

Eye of the Storm


Emile Bellott comments on the growing prominence of biosimilars, which are currently gaining visibility at the highest government levels, and some of the challenges this presents.
 
view
download pdf
bullet
RESEARCH AND DEVELOPMENT
Protein Structure

Multiple Choices


Before any biologic drug can be approved, the first crucial step is to obtain a full and accurate profile of the protein molecule – which can only be achieved by using a combination of techniques, states Iñigo Rodriguez-Mendieta at SGS.
 
view
download pdf
   
spacer
Edited by
Dr Deborah O'Neil,
Chief Executive and Scientific Officer,
NovaBiotics Ltd
Published quarterly in
January, April,
July, and October

News and Press Releases

Are you keeping up to date with changes to pharmaceutical laws and guidance?

The legal and regulatory environment affecting the pharmaceutical industry is in a period of unprecedented change. Are you keeping up with all these changes?
More info >>

White Papers

Clinical Trials in Russia Orange Paper: Summary of Year 2013

Synergy Research Group

Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

Industry Events

14th Annual Biomarkers Congress

21-22 February 2019, Manchester Central Convention Complex, UK

Oxford Global is proud to present for the 14th year our flagship Biomarkers Congress, taking place 21 – 22 February 2019 in Manchester, UK. An updated programme ensures you will benefit from talks on the latest strategies and technologies impacting growth in the biomarker industry.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement